Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

MNG842

90df1b91-8ff7-569b-be6c-22d037c5227a

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • INTERFERON_ALPHA_RESPONSE+0.286
  • TGF_BETA_SIGNALING+0.263
  • UV_RESPONSE_DN+0.260
  • WNT_BETA_CATENIN_SIGNALING+0.249
  • HEDGEHOG_SIGNALING+0.196
  • PEROXISOME+0.175
  • MITOTIC_SPINDLE+0.113
  • INTERFERON_GAMMA_RESPONSE+0.110
  • BILE_ACID_METABOLISM+0.089
  • APICAL_SURFACE+0.075

Top 10 suppressed

  • IL6_JAK_STAT3_SIGNALING-0.361
  • MTORC1_SIGNALING-0.351
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.333
  • UV_RESPONSE_UP-0.319
  • MYC_TARGETS_V2-0.278
  • OXIDATIVE_PHOSPHORYLATION-0.278
  • GLYCOLYSIS-0.277
  • MYC_TARGETS_V1-0.273
  • COMPLEMENT-0.263
  • PI3K_AKT_MTOR_SIGNALING-0.251

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1MNG320
mng-umap@100
0.821
2MBCproject_6016_T1_RNA
breast-umap@18
A0.773
3SRR8526730
lung-landscapes@6
cohortA10.761
4aMVAC.P_002_TURBT_S219
bladder-landscape@3
0.747
5TCGA-A7-A26J-01B-02R-A277-07
breast-umap@18
D0.739
6SRR33346954
bladder-landscape@3
0.738
7ULC1485T_S59
lung-landscapes@6
cohortA10.733
8X21fbbe96.619e.4fba.9a39.8f9098cb173e
lung-landscapes@6
cohortA10.729
9MNG423
mng-umap@100
0.725
10R15
bladder-landscape@3
0.724

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 10 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.286Inavolisib— uncovered
TGF_BETA_SIGNALING0.263Inavolisib— uncovered
UV_RESPONSE_DN0.260Inavolisib— uncovered
WNT_BETA_CATENIN_SIGNALING0.249Inavolisib— uncovered
HEDGEHOG_SIGNALING0.196Inavolisib— uncovered
PEROXISOME0.175Idelalisib— uncovered
MITOTIC_SPINDLE0.113Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.110Idelalisib— uncovered
BILE_ACID_METABOLISM0.089Inavolisib— uncovered
APICAL_SURFACE0.075Temsirolimus— uncovered